AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Silo Pharma, Inc. Director's Dealing 2022

Oct 5, 2022

35304_dirs_2022-10-04_00e97900-2566-46c4-8b69-251734f0f35e.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Silo Pharma, Inc. (SILO)
CIK: 0001514183
Period of Report: 2022-09-27

Reporting Person: Ryweck Daniel E. (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4000	Direct